{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fmedicalspecialtiespodcast.simplecast.com%2Fepisodes%2Femerging-nash-treatments-YJioqpbH","width":444,"version":"1.0","type":"rich","title":"Emerging NASH Treatments","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/dfbc663a-fe2c-4059-b006-a9d886413683/ms-podcast-icon-nash.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/137e002b-f0c0-4c71-a33e-bbfb7c3fbb3a\" height=\"200\" width=\"100%\" title=\"Emerging NASH Treatments\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Hear Philip N. Newsome, PhD, FRCPE, discuss the agents in late-phase clinical trials and their potential use in the treatment of NASH and fibrosis."}